Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
8.71
+0.10 (1.10%)
At close: May 13, 2026, 4:00 PM EDT
8.69
-0.02 (-0.17%)
After-hours: May 13, 2026, 4:10 PM EDT
Neogen Revenue
Neogen had revenue of $211.20M in the quarter ending February 28, 2026, a decrease of -4.43%. This brings the company's revenue in the last twelve months to $870.54M, down -3.92% year-over-year. In the fiscal year ending May 31, 2025, Neogen had annual revenue of $894.66M, down -3.20%.
Revenue (ttm)
$870.54M
Revenue Growth
-3.92%
P/S Ratio
2.17
Revenue / Employee
$292,724
Employees
2,974
Market Cap
1.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 894.66M | -29.56M | -3.20% |
| May 31, 2024 | 924.22M | 101.78M | 12.37% |
| May 31, 2023 | 822.45M | 295.29M | 56.01% |
| May 31, 2022 | 527.16M | 58.70M | 12.53% |
| May 31, 2021 | 468.46M | 50.29M | 12.03% |
| May 31, 2020 | 418.17M | 3.98M | 0.96% |
| May 31, 2019 | 414.19M | 16.26M | 4.09% |
| May 31, 2018 | 397.93M | 39.65M | 11.07% |
| May 31, 2017 | 358.28M | 37.00M | 11.52% |
| May 31, 2016 | 321.28M | 38.20M | 13.50% |
| May 31, 2015 | 283.07M | 35.67M | 14.42% |
| May 31, 2014 | 247.41M | 39.88M | 19.22% |
| May 31, 2013 | 207.53M | 23.48M | 12.76% |
| May 31, 2012 | 184.05M | 11.36M | 6.58% |
| May 31, 2011 | 172.68M | 32.17M | 22.90% |
| May 31, 2010 | 140.51M | 21.79M | 18.35% |
| May 31, 2009 | 118.72M | 16.30M | 15.92% |
| May 31, 2008 | 102.42M | 16.28M | 18.90% |
| May 31, 2007 | 86.14M | 13.71M | 18.92% |
| May 31, 2006 | 72.43M | 9.68M | 15.42% |
| May 31, 2005 | 62.76M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.29B |
| Enovis | 2.28B |
| Integer Holdings | 1.86B |
| Haemonetics | 1.33B |
| Inspire Medical Systems | 915.25M |
| NovoCure | 674.41M |
| TransMedics Group | 635.89M |
| UFP Technologies | 608.85M |
NEOG News
- 20 days ago - Neogen’s Listeria Right Now test receives AOAC PTM certification - TheFly
- 20 days ago - Neogen's Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification - Business Wire
- 4 weeks ago - Neogen Stock Tumbles. Why a Guidance Hike and Earnings Beat Aren't Helping. - Barrons
- 4 weeks ago - Neogen Earnings Call Transcript: Q3 2026 - Transcripts
- 4 weeks ago - Neogen reports Q3 adjusted EPS 9c, consensus 5c - TheFly
- 4 weeks ago - Options Volatility and Implied Earnings Moves Today, April 09, 2026 - TipRanks
- 4 weeks ago - Neogen raises FY26 revenue view to $857M-$860M from $845M-$855M - TheFly
- 4 weeks ago - Neogen Reports Third Quarter Fiscal Year 2026 Financial Results - Business Wire